FDA Inspection
TRUECARE BIOMEDIXTRUECARE BIOMEDIX – FDA Inspection, Mar 6, 2020
Record Details
This FDA Inspection record concerns TRUECARE BIOMEDIX, with an inspection on March 6, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- TRUECARE BIOMEDIX
- Inspection Date
- March 6, 2020
- Product Type
- Drugs
View Company Profile
ID · 1f37faa2-3429-4757-856f-2972511e68c3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1119892
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of TRUECARE BIOMEDIX
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2025 | Not classified | Office of Inspections and Investigations | |
| November 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for TRUECARE BIOMEDIX
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.